Effects of the Addition of Beta2-agonist Tulobuterol Patches to Inhaled Corticosteroid in Patients with Asthma

Effects of the Addition of Beta2-agonist Tulobuterol Patches to Inhaled Corticosteroid in Patients with Asthma

Background: Whether the additive effects of the tulobuterol patch (TP), the world’s first transdermal beta2-agonist preparation, are useful in asthma patients receiving inhaled corticosteroid (ICS) is unclear. To examine the add-on effects of TP on bronchial hyperresponsiveness and reduction of the...

Full description

Bibliographic Details
Main Authors: Soichiro Hozawa, Yoshinori Haruta, Michikazu Terada, Michio Yamakido
Format: Article
Language:English
Published: Elsevier 2009-01-01
Series:Allergology International
Subjects:
airway inflammation
bronchial asthma
bronchial hyperresponsiveness
inhaled corticosteroids
tulobuterol patch
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893015307358

Internet

http://www.sciencedirect.com/science/article/pii/S1323893015307358

Similar Items